NCT02071199View on ClinicalTrials.gov

Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS)

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Gingivitis
Interventions
DRUG

1X ACCS (Amnion-derived Cellular Cytokine Solution)

1X ACCS will be applied to the gingival margin daily 5 days per week for 2 weeks

DRUG

Normal saline

Saline will be applied to the gingival margin daily 5 days per week for 2 weeks

DRUG

0.3X ACCS

0.3X ACCS will be applied to the gingival margin daily 5 days per week for 2 weeks

Trial Locations (1)

02142

Forsyth Institute, Boston

Sponsors
All Listed Sponsors
lead

Noveome Biotherapeutics, formerly Stemnion

INDUSTRY

NCT02071199 - Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS) | Biotech Hunter | Biotech Hunter